You are here

Phase 2 data for ultra-long-acting insulin degludec show the potential to effectively lower blood sugar, including when used three times a week

Phase 2 data for ultra-long-acting insulin degludec show the potential to effectively lower blood sugar, including when used three times a week

Submitted by admin on June 26, 2010 - 10:15am

Source:

Pharmaceutical Processing

News Tags:

type 1 diabetes

Headline:

Phase 2 data for ultra-long-acting insulin degludec show the potential to effectively lower blood sugar, including when used three times a week